Clinical trial
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
NCT05300945 is registered in ClinicalTrials.gov with Zhixin Cao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
- Lead sponsor
- Zhixin Cao
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- January 1, 2023
- Completion date
- December 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer, peritoneal metastases